Ca2+ Dyshomeostasis Disrupts Neuronal and Synaptic Function in Alzheimer’s Disease
Open accessThe DOI matches its Crossref record; 242 of the 242 references it cites were found in a registry or an index.
Abstract
Ca2+ homeostasis is essential for multiple neuronal functions and thus, Ca2+ dyshomeostasis can lead to widespread impairment of cellular and synaptic signaling, subsequently contributing to dementia and Alzheimer’s disease (AD). While numerous studies implicate Ca2+ mishandling in AD, the cellular basis for loss of cognitive function remains under investigation. The process of synaptic degradation and degeneration in AD is slow, and constitutes a series of maladaptive processes each contributing to a further destabilization of the Ca2+ homeostatic machinery. Ca2+ homeostasis involves precise maintenance of cytosolic Ca2+ levels, despite extracellular influx via multiple synaptic Ca2+ channels, and intracellular release via organelles such as the endoplasmic reticulum (ER) via ryanodine receptor (RyRs) and IP3R, lysosomes via transient receptor potential mucolipin channel (TRPML) and two pore channel (TPC), and mitochondria via the permeability transition pore (PTP). Furthermore, functioning of these organelles relies upon regulated inter-organelle Ca2+ handling, with aberrant signaling resulting in synaptic dysfunction, protein mishandling, oxidative stress and defective bioenergetics, among other consequences consistent with AD. With few effective treatments currently available to mitigate AD, the past few years have seen a significant increase in the study of synaptic and cellular mechanisms as drivers of AD, including Ca2+ dyshomeostasis. Here, we detail some key findings and discuss implications for future AD treatments.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
![Figure 1 Synergistic Ca2+ interactions between RyR and glutamatergic synaptic transmission in AD mouse cortical neurons. (A) Pseudocolored images of relative Ca2+ changes in representative NonTg (top), TAS/TPM (a double transgenic AD mouse model) (middle), and 3xTg-AD (a triple transgenic AD mouse model) (bottom) neurons in the following conditions (from left to right): baseline 30 Hz synaptic stimulation (1.5 s), caffeine alone (10 mm), 30 Hz synaptic stimulation plus caffeine, and washout. (B) Representative Ca2+ response traces after 30 Hz synaptic stimulation (voltage trace shown in top) shown as percentage over baseline, in control aCSF (left panels) and in 10 mM caffeine (right panels) for NonTg (top), TAS/TPM (middle), and 3xTg-AD (bottom) neurons. (C) Bar graphs show averaged (mean ± SE) Ca2+ responses integrated over a 1.5 s time period of 30 Hz synaptic stimulation in control ACSF (left grouping), synaptic stimulation plus caffeine (center), and synaptic stimulation with ryanodine in the pipette (right grouping) for the NonTg, TAS/TPM, and 3xTg-AD neurons. Statistically significant differences are indicated by asterisks (one-way ANOVA, p < 0.05). * Significantly different from NonTg within treatment group; ** significantly different from synaptic stimulation in aCSF within transgenic strain (modified from [9]).](https://figures.cochat.ai/paper-figures/e9cb90741b9e4579b659f44d2690025a/ca2-dyshomeostasis-disrupts-neuronal-and-synaptic-function-in-alzheimers-disease-figure-1.jpg)


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Complexes formed by Aβ with α7-nAChR efficiently promote Aβ internalization and increased calcium influx, further affecting extracellular Aβ plaque accumulation and synaptic transmission.308”
From Recent advances in Alzheimer's disease: Mechanisms, clinical trials and new drug development strategies. (2024) · cites this paper as [308]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–242 of 242
Gobbi, P., Castaldo, P., Minelli, A., Salucci, S., Magi, S., Corcione, E., & Amoroso, S. (2007) · Pharmacological Research · doi:10.1016/j.phrs.2007.10.005 · Cited by 61
Krajnak, K., & Dahl, R. S. (2018) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2018.03.052 · Cited by 60
Hascup, K. N., & Hascup, E. R. (2016) · Journal of Alzheimer's Disease · doi:10.3233/jad-160041 · Cited by 57 · cited 1×
“Low micromolar concentrations of Aβ trigger glutamate release in the hippocampal dentate gyrus, CA3 and CA1 subfields via α7nAChRs [95] and picomolar concentrations of Aβ enhance hippocampal LTP via α7nAChRs [96].”
BackgroundSanMartín, C. D., Veloso, P., Adasme, T., Lobos, P., Bruna, B., Galaz, J., García, A., Hartel, S., Hidalgo, C., & Paula-Lima, A. C. (2017) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2017.00115 · Cited by 57
Gee, K. W., Olincy, A., Kanner, R., Johnson, L., Hogenkamp, D., Harris, J., Tran, M., Edmonds, S. A., Sauer, W., Yoshimura, R., et al. (2017) · Journal of Psychopharmacology · doi:10.1177/0269881117691590 · Cited by 56
Synaptotagmins in Neurodegeneration
Glavan, G., Schliebs, R., & Živin, M. (2009) · The Anatomical Record · doi:10.1002/ar.21026 · Cited by 51
Barbier, A. J., Hilhorst, M., Vliet, A. V., Snyder, P., Palfreyman, M. G., Gawryl, M., Dgetluck, N., Massaro, M., Tiessen, R., Timmerman, W., et al. (2015) · Clinical Therapeutics · doi:10.1016/j.clinthera.2014.09.013 · Cited by 51 · cited 1×
“EVP-6124 and the α7nAChR positive allosteric modulator AVL-3288 have been shown to be well tolerated in patients [104,105], but some concerns exist about effects of potentiation of α7nAChR mediated Ca2+ effects in AD.”
BackgroundMalsam, J., Bärfuss, S., Trimbuch, T., Zarebidaki, F., Sonnen, A. F.-P., Wild, K., Scheutzow, A., Rohland, L., Mayer, M. P., Sinning, I., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.107926 · Cited by 51
Foster, W. J., Taylor, H. B. C., Padamsey, Z., Jeans, A. F., Galione, A., & Emptage, N. J. (2018) · Science Signaling · doi:10.1126/scisignal.aat9093 · Cited by 50
Ca2+ permeability of nicotinic acetylcholine receptors in rat hippocampal CA1 interneurones
Fayuk, D., & Yakel, J. L. (2005) · The Journal of Physiology · doi:10.1113/jphysiol.2005.089789 · Cited by 48
Neely Kayala, K. M., Dickinson, G. D., Minassian, A., Walls, K. C., Green, K. N., & LaFerla, F. M. (2012) · Brain Research · doi:10.1016/j.brainres.2012.10.036 · Cited by 48
Texidó, L., Ros, E., Martı́n-Satué, M., López, S., Aleu, J., Marsal, J., & Solsona, C. (2005) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706221 · Cited by 47
Guerra‐Álvarez, M., Moreno‐Ortega, A. J., Navarro, E., Fernández‐Morales, J., Egea, J., López, M. G., & Cano‐Abad, M. F. (2015) · Journal of Neurochemistry · doi:10.1111/jnc.13049 · Cited by 46
Bertan, F., Wischhof, L., Sosulina, L., Mittag, M., Dalügge, D., Fornarelli, A., Gardoni, F., Marcello, E. E., Luca, M. D., Fuhrmann, M., et al. (2020) · Cell Death and Differentiation · doi:10.1038/s41418-020-0584-2 · Cited by 46
Calcium Signaling Deficits in Glia and Autophagic Pathways Contributing to Neurodegenerative Disease
Mustaly-Kalimi, S., Littlefield, A. M., & Stutzmann, G. E. (2018) · Antioxidants & Redox Signaling · doi:10.1089/ars.2017.7266 · Cited by 45
Self-citationCopenhaver, P. F., Anekonda, T. S., Musashe, D., Robinson, K. M., Ramaker, J. M., Swanson, T. L., Wadsworth, T. L., Kretzschmar, D., Woltjer, R. L., & Quinn, J. F. (2011) · Disease Models & Mechanisms · doi:10.1242/dmm.006841 · Cited by 44
Basal ryanodine receptor activity suppresses autophagic flux
Vervliet, T., Pintelon, I., Welkenhuyzen, K., Bootman, M. D., Bannai, H., Mikoshiba, K., Martinet, W., Kasri, N. N., Parys, J. B., & Bultynck, G. (2017) · Biochemical Pharmacology · doi:10.1016/j.bcp.2017.03.011 · Cited by 42
Memory and Learning Deficits Are Associated With Ca2+ Dyshomeostasis in Normal Aging
Uryash, A., Flores, V., Adams, J. A., Allen, P. D., & Lopez, J. R. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.00224 · Cited by 42
Aging-related changes in calcium-binding proteins in rat perirhinal cortex
Moyer, J. R., Furtak, S. C., McGann, J. P., & Brown, T. H. (2009) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2009.10.001 · Cited by 40
Phase II Crossover Trial of Varenicline in Mild-to-Moderate Alzheimer's Disease
Kim, S. Y., Choi, S. H., Rollema, H., Schwam, E. M., McRae, T., Dubrava, S., & Jacobsen, J. (2013) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000355373 · Cited by 40
Gibson, G. E., & Thakkar, A. (2017) · Neurochemical Research · doi:10.1007/s11064-017-2182-3 · Cited by 39
Ramos-Miguel, A., Sawada, K., Jones, A. A., Thornton, A. E., Barr, A. M., Leurgans, S. E., Schneider, J. A., Bennett, D. A., & Honer, W. G. (2017) · Acta Neuropathologica · doi:10.1007/s00401-016-1647-9 · Cited by 38
Regulation of Ca2+channels by SNAP-25 via recruitment of syntaxin-1 from plasma membrane clusters
Toft‐Bertelsen, T. L., Ziomkiewicz, I., Houy, S., Pinheiro, P. S., & Sørensen, J. B. (2016) · Molecular Biology of the Cell · doi:10.1091/mbc.e16-03-0184 · Cited by 38
Payne, A. J., Gerdes, B. C., Naumchuk, Y., McCalley, A. E., Kaja, S., & Koulen, P. (2013) · Experimental Neurology · doi:10.1016/j.expneurol.2013.09.001 · Cited by 37
Ondrejčák, T., Wang, Q., Kew, J. N. C., Virley, D. J., Upton, N., Anwyl, R., & Rowan, M. J. (2011) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2011.12.008 · Cited by 36
Functional Distribution of Nicotinic Receptors in CA3 Region of the Hippocampus
Grybko, M. J., Sharma, G., & Vijayaraghavan, S. (2009) · Journal of Molecular Neuroscience · doi:10.1007/s12031-009-9266-8 · Cited by 35
Murchison, D. A., McDermott, A. N., LaSarge, C. L., Peebles, K. A., Bizon, J. L., & Griffith, W. H. (2009) · Journal of Neurophysiology · doi:10.1152/jn.00301.2009 · Cited by 34
Thinschmidt, J. S., Frazier, C. J., King, M. A., Meyer, E. M., & Papke, R. L. (2005) · Neuroscience Letters · doi:10.1016/j.neulet.2005.07.038 · Cited by 32
Intranasal administration of dantrolene increased brain concentration and duration
Wang, J., Shi, Y., Yu, S., Wang, Y., Meng, Q., Liang, G., Eckenhoff, M. F., & Wei, H. (2020) · PLoS ONE · doi:10.1371/journal.pone.0229156 · Cited by 32
α7-nAChR agonist enhances neural plasticity in the hippocampus via a GABAergic circuit
Townsend, M., Whyment, A., Walczak, J.-S., Jeggo, R., van den Top, M., Flood, D. G., Leventhal, L., Patzke, H., & Koenig, G. (2016) · Journal of Neurophysiology · doi:10.1152/jn.00243.2016 · Cited by 29
Kroker, K. S., Moreth, J., Kußmaul, L., Rast, G. F., & Rosenbrock, H. (2013) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2013.04.006 · Cited by 27
Subcellular localization of ryanodine receptors in rat brain
Padua, R. A., Nagy, J. I., & Geiger, J. D. (1996) · European Journal of Pharmacology · doi:10.1016/0014-2999(95)00797-0 · Cited by 27
Briggs, C. A., Schneider, C., Richardson, J. C., & Stutzmann, G. E. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2012.12.013 · Cited by 27
Self-citationMitochondrial localization of NCXs: Balancing calcium and energy homeostasis
Magi, S., Piccirillo, S., Preziuso, A., Amoroso, S., & Lariccia, V. (2020) · Cell Calcium · doi:10.1016/j.ceca.2020.102162 · Cited by 26
The synaptic pathology of cognitive life
Honer, W. G., Ramos-Miguel, A., Alamri, J., Sawada, K., Barr, A. M., Schneider, J. A., & Bennett, D. A. (2019) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2019.21.3/whoner · Cited by 25
Schrank, S., McDaid, J., Briggs, C. A., Mustaly-Kalimi, S., Brinks, D., Houcek, A., Singer, O., Bottero, V., Marr, R. A., & Stutzmann, G. E. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21031030 · Cited by 22
Self-citationSynaptopodin Deficiency Ameliorates Symptoms in the 3xTg Mouse Model of Alzheimer's Disease
Aloni, E., Oni‐Biton, E., Tsoory, M., Moallem, D. H., & Segal, M. (2019) · Journal of Neuroscience · doi:10.1523/jneurosci.2920-18.2019 · Cited by 22
Piccirillo, S., Magi, S., Castaldo, P., Preziuso, A., Lariccia, V., & Amoroso, S. (2020) · Cell Calcium · doi:10.1016/j.ceca.2020.102160 · Cited by 22
Using Proteomics to Understand Alzheimer’s Disease Pathogenesis
Drummond, E., & Wısnıewskı, T. (2019) · Codon Publications eBooks · doi:10.15586/alzheimersdisease.2019.ch3 · Cited by 19
Magi, S., Piccirillo, S., Maiolino, M., Lariccia, V., & Amoroso, S. (2020) · Cell Calcium · doi:10.1016/j.ceca.2020.102268 · Cited by 18
Padamsey, Z., McGuinness, L., & Emptage, N. J. (2017) · Communicative & Integrative Biology · doi:10.1080/19420889.2017.1344802 · Cited by 15
Bertan, F., Wischhof, L., Sosulina, L., Mittag, M., Dalügge, D., Fornarelli, A., Gardoni, F., Marcello, E. E., Luca, M. D., Fuhrmann, M., et al. (2020) · Cell Death and Differentiation · doi:10.1038/s41418-020-00605-x · Cited by 15
Cited by
Zhang, J., Zhang, Y., Wang, J., Xia, Y., Zhang, J., & Chen, L. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01911-3 · Cited by 1,138
Alkhalifa, A. E., Alkhalifa, O., Durdanovic, I., Ibrahim, D. R., & Maragkou, S. (2025) · Journal of Dementia and Alzheimer's Disease · doi:10.3390/jdad2020017 · Cited by 66
Pathogenesis of sporadic Alzheimer's disease by deficiency of NMDA receptor subunit GluN3A
Zhong, W., Wu, A., Berglund, K., Gu, X., Jiang, M. Q., Talati, J., Zhao, J., Wei, L., & Yu, S. P. (2022) · Alzheimer's & Dementia · doi:10.1002/alz.12398 · Cited by 59
Webber, E. K., Fivaz, M., Stutzmann, G. E., & Griffioen, G. (2023) · Alzheimer's & Dementia · doi:10.1002/alz.13065 · Cited by 50
Self-citation[Retracted] A Review of Bile Acid Metabolism and Signaling in Cognitive Dysfunction‐Related Diseases
Weng, Z.-B., Chen, Y.-R., Lv, J.-T., Wang, M.-X., Chen, Z.-Y., Zhou, W., Shen, X.-C., Zhan, L.-B., & Wang, F. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/4289383 · Cited by 32
“In addition, recent studies have revealed that gut microbiota dysregulation [99, 100] and Ca2+ in fl ux [101, 102] are also closely associated with AD.”
Retracted
Metadata
- Authors
- McDaid, J., Mustaly-Kalimi, S., & Stutzmann, G. E.
- Affiliations
- Rosalind Franklin University of Medicine and Science (US)
- Corresponding author
- Stutzmann, Grace E.
- Venue
- Cells
- Publisher
- MDPI AG
- Published
- 2020-12-10
- Volume
- 9
- Issue
- 12
- Pages
- 2655
- ISSN
- 2073-4409 (ISSN-L)
- PMC
- PMC7763805
- OpenAlex
- W3112777679
- Cited by
- 73
- References
- 242
- Citations by year
- 2026: 9 · 2025: 18 · 2024: 16 · 2023: 11 · 2022: 12 · 2021: 7
- FWCI
- 0.95
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Cells (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Institutes of Health (NIA AG055497)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Physiology › Calcium signaling and nucleotide metabolism
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- calcium homeostasis, calcium dyshomeostasis, Alzheimer's disease, synaptic dysfunction, neuronal function, ryanodine receptor, IP3 receptor, TRPML, two-pore channels, mitochondrial permeability transition pore, oxidative stress, bioenergetics, dementia
- MeSH terms
- Alzheimer Disease, Cytosol, Endoplasmic Reticulum, Humans, Neurons, Synapses, Oxidative Stress, Ryanodine Receptor Calcium Release Channel, Calcium Signaling
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.